The supplementary analysis to improve optimal and precision therapy of glomerulonephritis
Not Applicable
- Conditions
- Renal Diseases a)IgA nephropathy, purpura nephritis b)lupus nephritis c)minimal change nephrotic syndrome, focal segmental glomerulosclerosis d)ANCA associated vasculitis and related diseases
- Registration Number
- JPRN-UMIN000033077
- Lead Sponsor
- agoya University Graduate School of Medicine, Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6500
Inclusion Criteria
Not provided
Exclusion Criteria
the patients who refuse consent (consent withdrawal)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a. eGFR 30% reduction, end-stage renal disease (initiation of dialysis therapy and renal transplantation) or death b. complete remission (proteinuria <0.3g/gCr or 0.3g/day)
- Secondary Outcome Measures
Name Time Method a. incomplete remission (proteinuria <1.0g/gCr or 1.0g/day) b. infectious hospitalization c. onset of diabetes mellitus d. cardiovascular event including myocardial infarction, angina pectoris, aortic dissection, aortic rupture and others e. stroke including cerebral hemorrhage, cerebral infarction, subarachnoid hemorrhage and others f. cancer